We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CZR icon
976
Caesars Entertainment
CZR
$6.1B
– –
-45,976
Closed -$1.83M
D icon
977
Dominion Energy
D
$62.7B
– –
-12,238
Closed -$600K
DAN icon
978
Dana Inc
DAN
$2.92B
– –
-10,602
Closed -$128K
DBRG icon
979
DigitalBridge
DBRG
$2.93B
– –
-29,035
Closed -$398K
DECK icon
980
Deckers Outdoor
DECK
$13.8B
– –
-3,438
Closed -$555K
DHT icon
981
DHT Holdings
DHT
$2.99B
– –
-15,563
Closed -$180K
DOCS icon
982
Doximity
DOCS
$3.81B
– –
-18,384
Closed -$514K
DRH icon
983
Diamondrock Hospitality Co
DRH
$2.6B
– –
-24,749
Closed -$209K
DRVN icon
984
Driven Brands
DRVN
$2.42B
– –
-10,769
Closed -$137K
DT icon
985
Dynatrace
DT
$12.7B
– –
-53,731
Closed -$2.4M
DVA icon
986
DaVita
DVA
$15.4B
– –
-3,013
Closed -$418K
DVN icon
987
Devon Energy
DVN
$50.2B
– –
-5,970
Closed -$283K
DXCM icon
988
DexCom
DXCM
$29.2B
– –
-17,094
Closed -$1.94M
EG icon
989
Everest Group
EG
$15.7B
– –
-1,535
Closed -$585K
EHC icon
990
Encompass Health
EHC
$11.5B
– –
-15,975
Closed -$1.37M
ELF icon
991
e.l.f. Beauty
ELF
$4.99B
– –
-2,338
Closed -$493K
ELME
992
Elme Communities
ELME
$142M
– –
-36,443
Closed -$581K
ELS icon
993
Equity Lifestyle Properties
ELS
$12.7B
– –
-18,413
Closed -$1.2M
EMBC icon
994
Embecta
EMBC
$209M
– –
-36,403
Closed -$455K
EME icon
995
Emcor
EME
$31.8B
– –
-4,094
Closed -$1.49M
ESGR
996
DELISTED
Enstar Group
ESGR
– –
-2,238
Closed -$684K
ESTA icon
997
Establishment Labs
ESTA
$2.74B
– –
-7,696
Closed -$350K
ETN icon
998
Eaton
ETN
$147B
– –
-7,396
Closed -$2.32M
ETR icon
999
Entergy
ETR
$53.4B
– –
-20,422
Closed -$1.09M
EVRI
1000
DELISTED
Everi Holdings
EVRI
– –
-123,958
Closed -$1.04M
38 39
40
41 42

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.